Literature DB >> 19824793

Clostridial toxins.

Michel R Popoff1, Philippe Bouvet.   

Abstract

Clostridia produce the highest number of toxins of any type of bacteria and are involved in severe diseases in humans and other animals. Most of the clostridial toxins are pore-forming toxins responsible for gangrenes and gastrointestinal diseases. Among them, perfringolysin has been extensively studied and it is the paradigm of the cholesterol-dependent cytolysins, whereas Clostridium perfringens epsilon-toxin and Clostridium septicum alpha-toxin, which are related to aerolysin, are the prototypes of clostridial toxins that form small pores. Other toxins active on the cell surface possess an enzymatic activity, such as phospholipase C and collagenase, and are involved in the degradation of specific cell-membrane or extracellular-matrix components. Three groups of clostridial toxins have the ability to enter cells: large clostridial glucosylating toxins, binary toxins and neurotoxins. The binary and large clostridial glucosylating toxins alter the actin cytoskeleton by enzymatically modifying the actin monomers and the regulatory proteins from the Rho family, respectively. Clostridial neurotoxins proteolyse key components of neuroexocytosis. Botulinum neurotoxins inhibit neurotransmission at neuromuscular junctions, whereas tetanus toxin targets the inhibitory interneurons of the CNS. The high potency of clostridial toxins results from their specific targets, which have an essential cellular function, and from the type of modification that they induce. In addition, clostridial toxins are useful pharmacological and biological tools.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19824793     DOI: 10.2217/fmb.09.72

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  62 in total

Review 1.  Targeting of the actin cytoskeleton by insecticidal toxins from Photorhabdus luminescens.

Authors:  Alexander E Lang; Gudula Schmidt; Joel J Sheets; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-11-12       Impact factor: 3.000

Review 2.  Inhibiting bacterial toxins by channel blockage.

Authors:  Sergey M Bezrukov; Ekaterina M Nestorovich
Journal:  Pathog Dis       Date:  2015-12-09       Impact factor: 3.166

3.  Vibrio vulnificus Secretes an Insulin-degrading Enzyme That Promotes Bacterial Proliferation in Vivo.

Authors:  In Hwang Kim; Ik-Jung Kim; Yancheng Wen; Na-Young Park; Jinyoung Park; Keun-Woo Lee; Ara Koh; Ji-Hyun Lee; Seung-Hoi Koo; Kun-Soo Kim
Journal:  J Biol Chem       Date:  2015-06-03       Impact factor: 5.157

Review 4.  Diversity, Structures, and Collagen-Degrading Mechanisms of Bacterial Collagenolytic Proteases.

Authors:  Yu-Zhong Zhang; Li-Yuan Ran; Chun-Yang Li; Xiu-Lan Chen
Journal:  Appl Environ Microbiol       Date:  2015-07-06       Impact factor: 4.792

Review 5.  Obstructing toxin pathways by targeted pore blockage.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Chem Rev       Date:  2012-10-11       Impact factor: 60.622

6.  Ischaemic intestinal perforation complicated by Clostridium perfringens sepsis in a diabetic patient.

Authors:  N T Mutters; S Stoffels; C Eisenbach; S Zimmermann
Journal:  Infection       Date:  2013-02-07       Impact factor: 3.553

Review 7.  Bacterial factors exploit eukaryotic Rho GTPase signaling cascades to promote invasion and proliferation within their host.

Authors:  Michel R Popoff
Journal:  Small GTPases       Date:  2014-05-08

8.  Characterization of Clostridium perfringens TpeL toxin gene carriage, production, cytotoxic contributions, and trypsin sensitivity.

Authors:  Jianming Chen; Bruce A McClane
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

9.  The CpAL quorum sensing system regulates production of hemolysins CPA and PFO to build Clostridium perfringens biofilms.

Authors:  Jorge E Vidal; Joshua R Shak; Adrian Canizalez-Roman
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

10.  Edema and tetraparesis in a miniature pig after allogeneic hematopoietic cell transplantation.

Authors:  Rebecca Crepeau; Abraham Matar; Thomas R Spitzer; Simon Robson; Vimukthi Pathiraja; David H Sachs; Christene A Huang; Raimon Duran-Struuck
Journal:  Comp Med       Date:  2012-08       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.